España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Cellectis
CLLS
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.10
-0.07
-3.23%
At Close: -
$2.14
0.04
1.90%
After Hours: 7:21 AM EDT
15 minutes delayed
Get Report
Comment
Cellectis (CLLS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cellectis (NASDAQ:CLLS) Stock
Cellectis Stock (NASDAQ: CLLS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, June 20, 2024
Cellectis Publishes Scientific Article Demons...
Benzinga Newsdesk
Tuesday, June 18, 2024
Cellectis Upgraded to Buy: Here's Why
Zacks
Wednesday, June 12, 2024
Cellectis Reports Publication Of A Scientific...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Cellectis...
Benzinga Newsdesk
Tuesday, June 04, 2024
Cellectis Says European Commission Has Grante...
Benzinga Newsdesk
Friday, May 31, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Tuesday, May 28, 2024
Cellectis Q1 Adj $(0.14) Beats $(0.33) Estima...
Benzinga Newsdesk
Tuesday, May 07, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, May 06, 2024
Cellectis shares are trading higher after the...
Benzinga Newsdesk
Cellectis Announces Completion Of AstraZeneca...
Benzinga Newsdesk
Thursday, May 02, 2024
Cellectis Appoints Arthur Stril As Interim Ch...
Benzinga Newsdesk
Monday, April 29, 2024
Cellectis Q4 2023 GAAP EPS $(0.64) Misses $(0...
Benzinga Newsdesk
Monday, April 22, 2024
Cellectis To Present Data On TALEN Editing Pr...
Benzinga Newsdesk
Wednesday, April 10, 2024
Cellectis Publishes Novel Intronic Gene Editi...
Benzinga Newsdesk
Monday, April 08, 2024
Cellectis Announces Two Poster Presentations ...
Benzinga Newsdesk
Wednesday, November 15, 2023
Cellectis Announces The Execution Of The Subs...
Benzinga Newsdesk
Monday, November 06, 2023
Cellectis Q3 2023 Adj EPS $(0.36) Beats $(0.4...
Benzinga Newsdesk
Earnings Scheduled For November 6, 2023
Benzinga Insights
Friday, November 03, 2023
Earnings Preview: Cellectis
Benzinga Insights
Thursday, November 02, 2023
Cellectis To Present Preliminary Results Of N...
Benzinga Newsdesk
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Why Roku Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Wednesday, November 01, 2023
Dow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged
Lisa Levin
Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today?
Vandana Singh
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Nasdaq Surges Over 100 Points Ahead Of Fed Decision; WeWork Shares Plunge
Lisa Levin
Cellectis shares are trading higher after the...
Benzinga Newsdesk
US Stocks Mixed; Private Sector Payrolls Increase Less Than Expected
Lisa Levin
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Market-Moving news for November 1st
Benzinga Newsdesk
Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, October 31, 2023
Cellectis Presents Pre-Clinical Data On Multi...
Benzinga Newsdesk
Tuesday, October 24, 2023
Cellectis Plans To Present Pre-Clinical Data ...
Benzinga Newsdesk
Thursday, October 12, 2023
Cellectis And Imagine Institute Publish A Pro...
Benzinga Newsdesk
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Wednesday, September 27, 2023
Cellectis To Present Pre-Clinical Data On Mul...
Benzinga Newsdesk
Tuesday, August 08, 2023
Oppenheimer Reiterates Outperform on Cellecti...
Benzinga Newsdesk
Monday, August 07, 2023
Cellectis Q2 Adj $(0.15) Beats $(0.45) Estima...
Benzinga Newsdesk
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, August 03, 2023
Cellectis Q2 Adj EPS $(0.15) Beats $(0.45) Es...
Benzinga Newsdesk
Earnings Scheduled For August 3, 2023
Benzinga Insights
Friday, June 09, 2023
Cellectis Presents Updated Clinical And Translational Data On BALLI-01 At The European Hematology Association 2023
Happy Mohamed
Wednesday, May 31, 2023
Cellectis Publishes Article In Cancer Immunol...
Benzinga Newsdesk
Wednesday, May 17, 2023
Cellectis Presents Clinical Data On AMELI-01 and Preclinical Data On Multiplex Engineering For Superior Generation Of CAR T-cells At ASGCT 2023
Happy Mohamed
Friday, May 12, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, May 11, 2023
Cellectis Announces Poster Presentation On BALLI-01 At The European Hematology Association 2023
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch